MR

Mridul Ranjan Khound

Active Director Director DIN 03069800
DIN 03069800 First appointment May 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Mridul Ranjan Khound

Data last updated:

Mridul Ranjan Khound is a Director at Eliezer Pharmaceuticals Private Limited (since 2010). The company operates in Healthcare.

DIN 03069800
Primary Designation Director
Industry Healthcare
First Appointment 26 May 2010
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20102010Active

Board colleagues of Mridul Ranjan Khound

Directorship timeline

Open interactive timeline →
Eliezer Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mridul Ranjan Khound

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mridul Ranjan Khound

Mridul Ranjan Khound currently holds 1 directorship: Eliezer Pharmaceuticals Private Limited (Director, since 26 May 2010).

Mridul Ranjan Khound was first appointed on 26 May 2010 as Director at Eliezer Pharmaceuticals Private Limited.

The current boards of Mridul Ranjan Khound's companies include Mandira Chettri (Eliezer Pharmaceuticals Private Limited), Nirmal Kumar Tamang (Eliezer Pharmaceuticals Private Limited), Rajiv Limboo (Eliezer Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available